Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;75(1):221-222.
doi: 10.1016/j.jhep.2021.04.021. Epub 2021 Apr 20.

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience

Nahum Méndez-Sánchez  1 , Luis Díaz-Orozco  2 , Jacqueline Córdova-Gallardo  3
Affiliations

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience

Nahum Méndez-Sánchez et al. J Hepatol. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript. Please refer to the accompanying ICMJE disclosure forms for further details.

Similar articles

  • Hepatologists' Awareness and Knowledge of NAFLD and the Familiarity with Renaming NAFLD to MAFLD.
    Alem SA, Fouad Y, AbdAllah M, Attia D, Kamal I, Said E, Gomaa A, Abd-Elsalam SM, Gaber Y. Alem SA, et al. Endocr Metab Immune Disord Drug Targets. 2024;24(12):1445-1453. doi: 10.2174/1871530323666221028154159. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 36306455
  • NAFLD, MAFLD and DAFLD.
    Mantovani A, Dalbeni A. Mantovani A, et al. Dig Liver Dis. 2020 Dec;52(12):1519-1520. doi: 10.1016/j.dld.2020.09.013. Epub 2020 Oct 2. Dig Liver Dis. 2020. PMID: 33012657 No abstract available.
  • The myth of the stigma of fatty liver: What does the evidence show?
    Ramírez-Mejía MM, Qi X, Abenavoli L, Méndez-Sánchez N. Ramírez-Mejía MM, et al. Ann Hepatol. 2024 Nov-Dec;29(6):101535. doi: 10.1016/j.aohep.2024.101535. Epub 2024 Aug 13. Ann Hepatol. 2024. PMID: 39147131 Review.
  • The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.
    Mendez-Sanchez N, Arrese M, Gadano A, Oliveira CP, Fassio E, Arab JP, Chávez-Tapia NC, Dirchwolf M, Torre A, Ridruejo E, Pinchemel-Cotrim H, Castellanos Fernández MI, Uribe M, Girala M, Diaz-Ferrer J, Restrepo JC, Padilla-Machaca M, Dagher L, Gatica M, Olaechea B, Pessôa MG, Silva M. Mendez-Sanchez N, et al. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):65-72. doi: 10.1016/S2468-1253(20)30340-X. Epub 2020 Nov 9. Lancet Gastroenterol Hepatol. 2021. PMID: 33181118 Review.
  • Redefining fatty liver disease: an international patient perspective.
    Shiha G, Korenjak M, Eskridge W, Casanovas T, Velez-Moller P, Högström S, Richardson B, Munoz C, Sigurðardóttir S, Coulibaly A, Milan M, Bautista F, Leung NWY, Mooney V, Obekpa S, Bech E, Polavarapu N, Hamed AE, Radiani T, Purwanto E, Bright B, Ali M, Dovia CK, McColaugh L, Koulla Y, Dufour JF, Soliman R, Eslam M. Shiha G, et al. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):73-79. doi: 10.1016/S2468-1253(20)30294-6. Epub 2020 Oct 5. Lancet Gastroenterol Hepatol. 2021. PMID: 33031758 Review.
See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources